COLUMN GROUP II, LP - Insider Non-Derivative Transactions at NGM BIOPHARMACEUTICALS INC (NGM) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jan 31, 2023, COLUMN GROUP II, LP's relationship to NGM BIOPHARMACEUTICALS INC (NGM) is TenPercentOwner, and currently has 927,231 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other NGM insiders.
Data Source: SEC.
COLUMN GROUP II, LP - Insider Non-Derivative Transactions of NGM Common Stock
COLUMN GROUP II, LP - Insider Non-Derivative Transactions at NGM
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 1, 2023 | P -- (Common Stock) | 176730 | 5 | 927231 |
| Jan 31, 2023 | P -- (Common Stock) | 7542 | 5 | 750501 |
| Jan 12, 2023 | P -- (Common Stock) | 209000 | 4.76 | 689542 |
| Jan 11, 2023 | P -- (Common Stock) | 100070 | 4.84 | 480542 |